Current role
Curtis Oltmans
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Curtis Oltmans
The proxy statement of Fulcrum Therapeutics, Inc. reports total compensation of $1,482,850 for Curtis Oltmans in fiscal 2025, including a base salary of $472,200. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Fulcrum Therapeutics, Inc. (FULC)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fulcrum Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Alex C. Sapir CEO, Board Member
- Bryan Stuart CEO, COO, Board Member
- Robert J. Gould CEO
- Kate Haviland Chairman
- Mark Levin Chairman
- Alan A. Musso CFO
- Peter Thomson CFO
- Robert E. Gould CFO
- Mel Hayes COO
- Alan Musso Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Fulcrum Therapeutics, Inc. (FULC) | Chief Legal Officer and Head of External Affairs | $472,200 | $1,482,850 |
| 2024 | Fulcrum Therapeutics, Inc. (FULC) | Chief Legal Officer and Head of External Affairs | $454,000 | $1,425,240 |
| 2023 | Fulcrum Therapeutics, Inc. (FULC) | Chief Legal Officer | $436,800 | $2,319,661 |
| 2020 | Fulcrum Therapeutics, Inc. (FULC) | — | $33,977 | $1,357,367 |
Recent activity
No call appearances or filed executive changes recorded yet.